arrow
G

Giorgio Soardo

University of Udine and Italian Liver Foundation
H指数:29
被引数:3,967

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Artificial intelligence as a ploy to delve into the intricate link between genetics and mitochondria in patients with MASLD

人工智能作为一种策略,以深入探究MASLD患者中遗传学与线粒体之间的复杂联系

2025-07-310
OAAI
Impact of clonal hematopoiesis of indeterminate potential on hepatocellular carcinoma in individuals with steatotic liver disease

不确定潜能克隆造血对脂肪性肝病个体肝细胞癌的影响

2024-03-111
OAAI
Impact of clonal hematopoiesis of indeterminate potential on hepatocellular carcinoma in individuals with steatotic liver disease
2024-02-010
OAAI
Interaction between estrogen receptor-α and PNPLA3 p.I148M variant drives fatty liver disease susceptibility in women (vol 29, pg 2643, 2023)
2024-01-240
OAAI
Hepatic encephalopathy increases the risk for mortality and hospital readmission in decompensated cirrhotic patients: a prospective multicenter study

肝性脑病增加失代偿期肝硬化患者的死亡率和再入院风险: 一项前瞻性多中心研究

2023-05-256
OAAI
Rare ATG7 genetic variants predispose patients to severe fatty liver disease

罕见的ATG7遗传变异使患者易患严重脂肪肝疾病

2022-09-0148
OA
TM6SF2/PNPLA3/MBOAT7 Loss-of-Function Genetic Variants Impact on NAFLD Development and Progression Both in Patients and in In Vitro Models

TM6SF2/PNPLA3/MBOAT7功能缺失遗传变异对患者和体外模型NAFLD发生和进展的影响

2022-01-0161
OAAI
Obesity Modifies the Performance of Fibrosis Biomarkers in Nonalcoholic Fatty Liver Disease

肥胖改变纤维化生物标志物在非酒精性脂肪性肝病中的表现

2021-12-3139
OA
Non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scores

使用多基因风险评分对非酒精性脂肪肝的肝细胞癌风险进行非侵入性分层

2021-04-01226
OAAI